160 related articles for article (PubMed ID: 22416383)
1. [Detection and treatment of ductal carcinoma of the breast].
Semiglazov VV; Tabagua TT; Matsko DE
Vopr Onkol; 2011; 57(6):699-701. PubMed ID: 22416383
[No Abstract] [Full Text] [Related]
2. An unusual triple-negative breast carcinoma.
Shousha S; Peston D; Gojis O; Palmieri C
Histopathology; 2009 Sep; 55(3):364-6. PubMed ID: 19723156
[No Abstract] [Full Text] [Related]
3. Triple-negative breast cancers: unique clinical presentations and outcomes.
Billar JA; Dueck AC; Stucky CC; Gray RJ; Wasif N; Northfelt DW; McCullough AE; Pockaj BA
Ann Surg Oncol; 2010 Oct; 17 Suppl 3():384-90. PubMed ID: 20853062
[TBL] [Abstract][Full Text] [Related]
4. Quality indicators for the care of breast cancer in vulnerable elders.
Naeim A; Sawhney R; MacLean CH; Sanati H
J Am Geriatr Soc; 2007 Oct; 55 Suppl 2():S258-69. PubMed ID: 17910546
[No Abstract] [Full Text] [Related]
5. High tumoral levels of Kiss1 and G-protein-coupled receptor 54 expression are correlated with poor prognosis of estrogen receptor-positive breast tumors.
Marot D; Bieche I; Aumas C; Esselin S; Bouquet C; Vacher S; Lazennec G; Perricaudet M; Kuttenn F; Lidereau R; de Roux N
Endocr Relat Cancer; 2007 Sep; 14(3):691-702. PubMed ID: 17914099
[TBL] [Abstract][Full Text] [Related]
6. Pigmented Cutaneous Metastasis of Breast Carcinoma Mimicking a Melanoma.
Ubillos N; Vola M; Mazzei ME; Magliano J
Actas Dermosifiliogr; 2016 Oct; 107(8):699-701. PubMed ID: 27206606
[No Abstract] [Full Text] [Related]
7. Overview of breast cancer.
Watkins EJ
JAAPA; 2019 Oct; 32(10):13-17. PubMed ID: 31513033
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor in breast ductal carcinoma in situ: good cop, bad cop?
DeCensi A; Pruneri G; Guerrieri-Gonzaga A
J Clin Oncol; 2012 Apr; 30(12):1384-6. PubMed ID: 22393083
[No Abstract] [Full Text] [Related]
9. Pathological definition of triple negative breast cancer.
Viale G; Bottiglieri L
Eur J Cancer; 2009 Sep; 45 Suppl 1():5-10. PubMed ID: 19775600
[No Abstract] [Full Text] [Related]
10. The presence of alveolar structures in invasive ductal NOS breast carcinoma is associated with lymph node metastasis.
Zavyalova MV; Perelmuter VM; Vtorushin SV; Denisov EV; Litvyakov NV; Slonimskaya EM; Cherdyntseva NV
Diagn Cytopathol; 2013 Mar; 41(3):279-82. PubMed ID: 22102485
[No Abstract] [Full Text] [Related]
11. Expression of estrogen and progesterone receptors in human ductal invasive breast carcinoma not otherwise specified: is there any difference between premenopausal and postmenopausal women?
Petricević J; Petković M; Jonjić N
Acta Clin Croat; 2011 Jun; 50(2):169-75. PubMed ID: 22263379
[TBL] [Abstract][Full Text] [Related]
12. [Detection and assessment of Ki-67 in breast cancer].
Shui RH; Yang WT
Zhonghua Bing Li Xue Za Zhi; 2013 Jun; 42(6):420-3. PubMed ID: 24060083
[No Abstract] [Full Text] [Related]
13. Pure or mixed-type invasive lobular carcinoma?
Bulut N; Dede DS; Sari E; Altundag K
Hum Pathol; 2008 Jul; 39(7):1121; author reply 1121. PubMed ID: 18570979
[No Abstract] [Full Text] [Related]
14. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
Hussein MR; Abd-Elwahed SR; Abdulwahed AR
Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
[TBL] [Abstract][Full Text] [Related]
15. [Immunohistochemical investigation of steroid hormones (ER, PR) in breast cancer].
Mchedlishvili MIu; Gabunia UA; Makharoblidze ER; Burnadze KT; Piradashvili DZ
Georgian Med News; 2005 Feb; (119):65-7. PubMed ID: 15834186
[TBL] [Abstract][Full Text] [Related]
16. [Zosteriform eruption resistant to acyclovir].
Orgaz-Molina J; Cotugno M; Aneiros-Fernández J; Arias-Santiago S
Med Clin (Barc); 2013 Aug; 141(4):188. PubMed ID: 23597955
[No Abstract] [Full Text] [Related]
17. Dose-dense and/or metronomic schedules of specific chemotherapies consolidate the chemosensitivity of triple-negative breast cancer: a step toward reversing triple-negative paradox.
Mehta RS
J Clin Oncol; 2008 Jul; 26(19):3286-8; author reply 3288. PubMed ID: 18591566
[No Abstract] [Full Text] [Related]
18. Clinical and biological characteristics of breast cancer.
Kocic B; Filipovic S; Petrovic B; Mijalkovic D; Rancic N; Poultsidi A
J BUON; 2010; 15(4):660-7. PubMed ID: 21229626
[TBL] [Abstract][Full Text] [Related]
19. The prognostic relevance of estimates of proliferative activity in early breast cancer.
Heatley MK; Maxwell P; Whiteside C; Ewing P; Toner PG
Histopathology; 2005 Jan; 46(1):110-1. PubMed ID: 15656896
[No Abstract] [Full Text] [Related]
20. Risk factors and hormone-receptor status: epidemiology, risk-prediction models and treatment implications for breast cancer.
Chen WY; Colditz GA
Nat Clin Pract Oncol; 2007 Jul; 4(7):415-23. PubMed ID: 17597706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
